1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. LANDOS BIOPHARMA INC

Landos Biopharma Inc

XNAS: LABP

Watchlist

Portfolio

Share


Insider Trading disclosures for Landos Biopharma Inc

The latest disclosure was made by Fabio Cataldi in Landos Biopharma Inc where a trade of 21,138 Restricted Stock Unit done was reported to US exchanges on Feb. 29, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Fabio Cataldi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 21,138 21,138 - - Restricted Stock Unit
Gregory Oakes Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 54,454 54,454 - - Restricted Stock Unit
Alka Batycky Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2023 3,600 3,600 - - Stock Option (right to buy)
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 18,000 18,000 - - Stock Option (right to buy)
Tiago M. Girao Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 18,000 18,000 - - Stock Option (right to buy)
Roger Adsett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 18,000 18,000 - - Stock Option (right to buy)
Frederick C. Callori Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 18,000 18,000 - - Stock Option (right to buy)
Christopher Nishan Garabedian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2023 18,000 18,000 - - Stock Option (right to buy)
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Feb 2023 3,470,736 0 - - common stock
Gregory Oakes Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 475,300 475,300 - - Employee Stock Option (right to buy)
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Feb 2023 500,000 0 - - common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Feb 2023 467,306 0 - - common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Feb 2023 496,527 0 - - common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Feb 2023 786,299 0 - - common stock
Patrick Truesdell Vice President and Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 99,600 99,600 - - Restricted Stock Unit
Patrick Truesdell Vice President and Controller Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 99,600 99,600 - - Employee Stock Option (right to buy)
Fabio Cataldi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 184,500 184,500 - - Employee Stock Option (right to buy)
Fabio Cataldi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 276,750 276,750 - - Restricted Stock Unit
Josep Bassaganya-Riera Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2022 650,000 5,720,868 - 0 common stock
Fabio Cataldi Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Sep 2022 400,000 400,000 - - Employee Stock Option (right to buy)
Josep Bassaganya-Riera Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 05 Aug 2022 500,000 3,494,208 - 0 common stock
Josep Bassaganya-Riera Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 05 Aug 2022 500,000 500,000 - 0 common stock
Gregory Oakes Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2022 1,677,251 1,677,251 - - Employee Stock Option (right to buy)
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Christopher Nishan Garabedian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Frederick C. Callori Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Roger Adsett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Tiago M. Girao Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 18,000 18,000 - - Stock Option (right to buy)
Christopher Nishan Garabedian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2022 18,000 18,000 - - Stock Option (right to buy)
Frederick C. Callori Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2022 18,000 18,000 - - Stock Option (right to buy)
Tiago M. Girao Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2022 18,000 18,000 - - Stock Option (right to buy)
Roger Adsett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2022 36,000 36,000 - - Stock Option (right to buy)
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 4.75 per share. 16 Dec 2021 33,194 4,994,208 - 4.8 157,804 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 4.84 per share. 16 Dec 2021 36,000 5,027,402 - 4.8 174,096 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 5.11 per share. 16 Dec 2021 24,301 5,063,402 - 5.1 124,251 common stock
Josep Bassaganya-Riera Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 16 Dec 2021 58,651 5,087,703 - 0 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 5.10 per share. 13 Dec 2021 42,000 5,189,354 - 5.1 214,284 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 5.02 per share. 13 Dec 2021 43,000 5,146,354 - 5.0 216,032 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 5.37 per share. 13 Dec 2021 40,000 5,231,354 - 5.4 214,840 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 6.58 per share. 06 Dec 2021 42,000 5,348,046 - 6.6 276,528 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 6.65 per share. 06 Dec 2021 25,530 5,322,516 - 6.6 169,723 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 6.17 per share. 06 Dec 2021 36,000 5,390,046 - 6.2 221,976 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 7.06 per share. 29 Nov 2021 35,000 7,393,152 - 7.1 247,170 common stock
Josep Bassaganya-Riera Ten Percent Owner Sale of securities on an exchange or to another person at price $ 7.57 per share. 29 Nov 2021 15,430 7,428,152 - 7.6 116,882 common stock
Fred Callori Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2021 36,000 36,000 - - Stock Option (right to buy)
Jyoti Chauhan ED, Global Clinical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jul 2021 118,054 155,681 - - Stock Option (right to buy)
Jyoti Chauhan ED, Global Clinical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. 26 Jul 2021 118,054 209,299 - 1.9 219,580 Common Stock
Timothy M. Mayleben Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 36,000 36,000 - - Stock Option (right to buy)
Tiago M. Girao Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 36,000 36,000 - - Stock Option (right to buy)
Konstantin Poukalov Director, Ten Percent Owner 08 Feb 2021 13,369,728 13,369,728 - - Common Stock
Konstantin Poukalov Director, Ten Percent Owner 08 Feb 2021 5,883,538 0 - - Series A Preferred Stock
Konstantin Poukalov Director, Ten Percent Owner 08 Feb 2021 7,486,190 0 - - Series B Preferred Stock
Konstantin Poukalov Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 16.00 per share. 08 Feb 2021 1,250,000 14,619,728 - 16 20,000,000 Common Stock
Konstantin Poukalov Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 11.14 per share. 05 Feb 2021 27,453 14,647,181 - 11.1 305,826 Common Stock
Konstantin Poukalov Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 14.60 per share. 05 Feb 2021 34,951 14,869,915 - 14.6 510,285 Common Stock
Konstantin Poukalov Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.80 per share. 05 Feb 2021 64,730 14,834,964 - 13.8 893,274 Common Stock
Konstantin Poukalov Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.10 per share. 05 Feb 2021 1,771 14,770,234 - 13.1 23,200 Common Stock
Konstantin Poukalov Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 11.38 per share. 05 Feb 2021 34,611 14,681,792 - 11.4 393,873 Common Stock
Konstantin Poukalov Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 12.53 per share. 05 Feb 2021 86,671 14,768,463 - 12.5 1,085,988 Common Stock
Raquel Hontecillas Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 250,604 250,604 - - Stock Option (right to buy)
Jyoti Chauhan ED, Global Clinical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2021 250,604 250,604 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters